Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Oktober 2025 08:18 ET | Quelle: Bleichmar Fonti & Auld

MLTX SECURITIES NOTICE: MoonLake Immunotherapeutics Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
08. Oktober 2025 07:36 ET | Quelle: Bleichmar Fonti & Auld

MLTX INQUIRY NOTICE: MoonLake Immunotherapeutics Hit with Securities Fraud Investigation Due to Drug Trial Results -- Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.
06. Oktober 2025 14:35 ET | Quelle: Block & Leviton LLP

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation

MoonLake Immunotherapeutics Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation.
29. September 2025 10:53 ET | Quelle: Block & Leviton LLP

BREAKING: MoonLake Immunotherapeutics Shares Down Over 85%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Shares of MoonLake Immunotherapeutics are down over 85% today. Block & Leviton is investigating MoonLake's public statements about its drug trials.